Radio Enhancer
MTL-005 is a radio-enhancer, designed to preferentially accumulate in tumours and amplify the effect of radiotherapy without affecting surrounding cells.
Find out more"Radiotherapy still produces a high rate of local failure in spite of all the technologies. So, true radiation-modifying drugs or radiation-sensitizing drugs could have a huge market."Key Opinion Leader
Clinical Trials
A Phase 1 clinical trial in head and neck cancer is underway, with centres across the UK actively recruiting patients.
Find out more
Global Licensing Opportunity
MorEx is seeking an experienced development and commercialisation partner to continue the MTL-005 clinical programme.
Find out more